Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.

Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.

Jacobs A, Tjuvajev JG, Dubrovin M, Akhurst T, Balatoni J, Beattie B, Joshi R, Finn R, Larson SM, Herrlinger U, Pechan PA, Chiocca EA, Breakefield XO, Blasberg RG.

Cancer Res. 2001 Apr 1;61(7):2983-95.

2.

Herpes simplex virus thymidine kinase as a marker/reporter gene for PET imaging of gene therapy.

Blasberg RG, Tjuvajev JG.

Q J Nucl Med. 1999 Jun;43(2):163-9. Review.

PMID:
10429512
3.

2'-Fluoro-2'-deoxy-5'-[123/124/125/131I]iodo-1β-d-arabinofuranosyluracil.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2005 Feb 1 [updated 2005 Feb 9].

4.

1-(2'-Deoxy-2'-[18F]fluoro-β-d-arabinofuranosyl)-5-iodocytosine.

Shan L.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2012 Mar 19 [updated 2012 Apr 11].

5.

Assays for noninvasive imaging of reporter gene expression.

Gambhir SS, Barrio JR, Herschman HR, Phelps ME.

Nucl Med Biol. 1999 Jul;26(5):481-90. Review.

PMID:
10473186
6.

Thymidine kinase gene transfer by herpes simplex virus.

Kraiselburd E.

Bull Cancer. 1976 Jul-Sep;63(3):393-8. Review.

PMID:
187268
7.

9-(4-[18F]Fluoro-3-hydroxymethylbutyl)guanine.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2005 Jan 24 [updated 2005 Feb 23].

8.

Radiolabeled nucleoside analogues for PET imaging of HSV1-tk gene expression.

Alauddin MM, Gelovani JG.

Curr Top Med Chem. 2010;10(16):1617-32. Review.

PMID:
20583993
9.
10.

In situ use of suicide genes for therapy of brain tumours.

Wildner O.

Ann Med. 1999 Dec;31(6):421-9. Review.

PMID:
10680856
11.

Combination of pet imaging with viral vectors for identification of cancer metastases.

Brader P, Wong RJ, Horowitz G, Gil Z.

Adv Drug Deliv Rev. 2012 Jun 1;64(8):749-55. doi: 10.1016/j.addr.2011.04.007. Epub 2011 Apr 30. Review.

PMID:
21565234
12.

[Herpes simplex type-1 virus-based vectors for gene therapy].

Ichikawa T, Saeki Y, Tamiya T, Chiocca EA, Ohmoto T.

Nihon Rinsho. 2000 Apr;58(4):822-7. Review. Japanese.

PMID:
10774201
13.

HSV-1-derived helper-independent defective vectors, replicating vectors and amplicon vectors, for the treatment of brain diseases.

Marconi P, Manservigi R, Epstein AL.

Curr Opin Drug Discov Devel. 2010 Mar;13(2):169-83. Review.

PMID:
20205051
14.

Gene transfer to muscle using herpes simplex virus-based vectors.

Huard J, Krisky D, Oligino T, Marconi P, Day CS, Watkins SC, Glorioso JC.

Neuromuscul Disord. 1997 Jul;7(5):299-313. Review.

PMID:
9267843
15.

Medical application of herpes simplex virus.

Watanabe D.

J Dermatol Sci. 2010 Feb;57(2):75-82. doi: 10.1016/j.jdermsci.2009.10.014. Epub 2009 Nov 24. Review.

PMID:
19939634
16.

[Future directions of gene therapy for lung cancer].

Hasegawa Y, Shimokata K.

Nihon Kyobu Shikkan Gakkai Zasshi. 1995 Dec;33 Suppl:33-7. Review. Japanese.

PMID:
8752480
17.

Use of herpes simplex virus type 1 for transgene expression within the nervous system.

Lachmann RH, Efstathiou S.

Clin Sci (Lond). 1999 Jun;96(6):533-41. Review.

PMID:
10334958
19.

[Gene therapy with vector-producing multipotent mesenchymal stromal cells].

Okada T.

Yakugaku Zasshi. 2010 Nov;130(11):1513-8. Review. Japanese.

20.

Hybrid vector designs to control the delivery, fate and expression of transgenes.

Lam PY, Breakefield XO.

J Gene Med. 2000 Nov-Dec;2(6):395-408. Review.

PMID:
11199260

Supplemental Content

Support Center